A little competition can greatly benefit patients. Shareholders may have a more difficult path to navigate.

Jim Cramer says stocks are caught between the forces of inflation and deflation, and investors need to find companies that can adapt.

Cathie Wood's Ark Investment bought shares of Germany’s Crispr Tuesday, a media report says. The stock slid on Wednesday.

'These data open a new era of medicine – one that holds the potential of curing genetic disease,' Intellia said. Its shares are higher.

Intellia Therapeutics rises and other gene-editing stocks follow suit.

Tesla CEO Musk discusses succession plans and Twitter with shareholders.

The company has made clear what it plans on the Las Vegas Strip, but it has a fast-approaching deadline.

Long-delayed futuristic looking electric vehicle will be in production by the middle of 2023